ADMINISTRATION OF COLONY STIMULATING FACTOR-I CORRECTS SOME MACROPHAGE, DENTAL, AND SKELETAL DEFECTS IN AN OSTEOPETROTIC MUTATION (TOOTHLESS, TL) IN THE RAT

被引:85
作者
MARKS, SC
WOJTOWICZ, A
SZPERL, M
URBANOWSKA, E
MACKAY, CA
WIKTORJEDRZEJCZAK, W
STANLEY, ER
AUKERMAN, SL
机构
[1] WARSAW ACAD MED & HOSP,INST BIOSTRUCT,WARSAW,POLAND
[2] MIL MED ACAD,DEPT IMMUNOL,WARSAW,POLAND
[3] YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT DEV BIOL & CANC,BRONX,NY 10461
[4] CETUS CORP,DEPT PHARMACOL,EMERYVILLE,CA 94608
关键词
COLONY STIMULATING FACTOR-I (CSF-1); MACROPHAGE-COLONY STIMULATING FACTOR (M-CSF); OSTEOPETROSIS; RAT; OSTEOCLAST; MACROPHAGE; TOOTH ERUPTION;
D O I
10.1016/8756-3282(92)90365-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The toothless (tl/tl) mutation in the rat results in a paucity of osteoclasts and osteopetrosis that cannot be corrected by bone marrow transplantation. In the present study we demonstrate that tl/tl rats also have profound deficiencies of femoral, peritoneal, and pleural cavity macrophages. Furthermore, the macrophage colony stimulating activity of post-endotoxin sera from tl/tl rats is substantially reduced, suggesting that, as in the case of the op mutation in mice, the basis of the tl mutation is a deficiency of the macrophage growth factor, colony stimulating factor-1 (CSF-1). Consistent with this suggestion, treatment of tl/tl rats from birth for up to six weeks with CSF-1 reduced the osteopetrosis, increased body weight, and permitted tooth eruption. In addition, CSF-1 treatment induced large numbers of osteoclasts in tl/tl bones and macrophages in the peritoneal cavity and bone marrow. Persistence of metaphyseal sclerosis, however, indicated that the disease was not totally corrected by this treatment. These studies indicate that the basis of the tl mutation is most likely another CSF-1 deficiency, and further emphasize the role of this growth factor in osteoclast differentiation.
引用
收藏
页码:89 / 93
页数:5
相关论文
共 32 条
  • [1] GROWTH OF MOUSE BONE MARROW CELLS IN VITRO
    BRADLEY, TR
    METCALF, D
    [J]. AUSTRALIAN JOURNAL OF EXPERIMENTAL BIOLOGY AND MEDICAL SCIENCE, 1966, 44 : 287 - &
  • [2] CHEN BDM, 1991, BLOOD, V77, P1923
  • [3] COTTON WR, 1974, P SOC EXP BIOL MED, V146, P554, DOI 10.3181/00379727-146-38146
  • [4] EKRYLANDER B, 1989, BONE MIN, V5, P3089
  • [5] MACROPHAGE COLONY STIMULATING FACTOR RESTORES INVIVO BONE-RESORPTION IN THE OP/OP OSTEOPETROTIC MOUSE
    FELIX, R
    CECCHINI, MG
    FLEISCH, H
    [J]. ENDOCRINOLOGY, 1990, 127 (05) : 2592 - 2594
  • [6] FELIX R, 1990, J BONE MINER RES, V5, P781
  • [7] RENATURATION AND PURIFICATION OF BIOLOGICALLY-ACTIVE RECOMBINANT HUMAN MACROPHAGE COLONY-STIMULATING FACTOR EXPRESSED IN ESCHERICHIA-COLI
    HALENBECK, R
    KAWASAKI, E
    WRIN, J
    KOTHS, K
    [J]. BIO-TECHNOLOGY, 1989, 7 (07): : 710 - 715
  • [8] MACROPHAGE COLONY STIMULATING FACTOR (M-CSF) IS ESSENTIAL FOR OSTEOCLAST FORMATION INVITRO
    HATTERSLEY, G
    OWENS, J
    FLANAGAN, AM
    CHAMBERS, TJ
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 177 (01) : 526 - 531
  • [9] CONGENITAL OSTEOCLAST DEFICIENCY IN OSTEOPETROTIC (OP/OP) MICE IS CURED BY INJECTIONS OF MACROPHAGE COLONY-STIMULATING FACTOR
    KODAMA, H
    YAMASAKI, A
    NOSE, M
    NIIDA, S
    OHGAME, Y
    ABE, M
    KUMEGAWA, M
    SUDA, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (01) : 269 - 272
  • [10] ESSENTIAL ROLE OF MACROPHAGE COLONY-STIMULATING FACTOR IN THE OSTEOCLAST DIFFERENTIATION SUPPORTED BY STROMAL CELLS
    KODAMA, H
    NOSE, M
    NIIDA, S
    YAMASAKI, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (05) : 1291 - 1294